James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
UNH holding history
UnitedHealth Group Inc in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
UNH overviewAll 13F holders of UNHFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −245,642−100.0% | Sold out | Holders |
| Q1 2025 | 245,642 | $128.6M | 5.4% | +14,784+6.4% | Added | Holders |
| Q4 2024 | 230,858 | $116.9M | 4.6% | +3,434+1.5% | Added | Holders |
| Q3 2024 | 227,424 | $133.0M | 5.5% | +8,573+3.9% | Added | Holders |
| Q2 2024 | 218,851 | $111.4M | 5.2% | +12,106+5.9% | Added | Holders |
| Q1 2024 | 206,745 | $102.2M | 4.8% | +14,019+7.3% | Added | Holders |
| Q4 2023 | 192,726 | $101.5M | 5.4% | +9,823+5.4% | Added | Holders |
| Q3 2023 | 182,903 | $92.2M | 6.0% | +19,564+12.0% | Added | Holders |
| Q2 2023 | 163,339 | $78.5M | 5.2% | +9,032+5.9% | Added | Holders |
| Q1 2023 | 154,307 | $72.9M | 5.3% | +8,224+5.6% | Added | Holders |
| Q4 2022 | 146,083 | $77.5M | 5.9% | −7,289−4.8% | Reduced | Holders |
| Q3 2022 | 153,372 | $77.6M | 6.8% | −10,066−6.2% | Reduced | Holders |
| Q2 2022 | 163,438 | $84.2M | 7.0% | −4,557−2.7% | Reduced | Holders |
| Q1 2022 | 167,995 | $85.7M | 6.1% | −2,346−1.4% | Reduced | Holders |
| Q4 2021 | 170,341 | $85.5M | 5.8% | +9,907+6.2% | Added | Holders |
| Q3 2021 | 160,434 | $62.7M | 4.7% | +6,386+4.1% | Added | Holders |
| Q2 2021 | 154,048 | $61.7M | 4.9% | +3,785+2.5% | Added | Holders |
| Q1 2021 | 150,263 | $56.0M | 5.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.